{"id":167018,"date":"2025-02-21T05:53:43","date_gmt":"2025-02-21T10:53:43","guid":{"rendered":"https:\/\/44.250.171.167\/?p=167018"},"modified":"2025-02-21T05:53:43","modified_gmt":"2025-02-21T10:53:43","slug":"ajanta-pharma-ltd-q3fy25-11-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q3fy25-11-rise-in-profits\/","title":{"rendered":"Ajanta Pharma Ltd Q3FY25; 11% rise in Profits"},"content":{"rendered":"<p>Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).<\/p>\n<p>Financial Results:<\/p>\n<p>Ajanta Pharma Ltd reported Revenues for Q3FY25 of \u20b91,146.00 Crores up from \u20b91,105.00 Crore year on year, a rise of 3.71%.<\/p>\n<p>Total Expenses for Q3FY25 of \u20b9869.00 Crores up from \u20b9827.00 Crores year on year, a rise of 5.08%.<\/p>\n<p>Consolidated Net Profit of \u20b9233.00 Crores up 10.95% from \u20b9210.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b918.64, up 13.73% from \u20b916.39 in the same quarter of the previous year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-167019\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12.png\" alt=\"\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q3FY25 of \u20b91,146.00 Crores up from \u20b91,105.00 Crore year on year, a rise of 3.71%. Total Expenses for Q3FY25 of \u20b9869.00 Crores up from \u20b9827.00 [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":167019,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-167018","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":165443,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q2fy25-11-rise-in-profits\/","url_meta":{"origin":167018,"position":0},"title":"Ajanta Pharma Ltd Q2FY25; 11% rise in Profits","author":"Divyansh_Kasana","date":"November 7, 2024","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q2FY25 of \u20b91,187.00 Crores up from \u20b91,028.00 Crore year on year, a rise of 15.47%. Total Expenses for Q2FY25 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168654,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q4fy25-11-rise-in-profits\/","url_meta":{"origin":167018,"position":1},"title":"Ajanta Pharma Ltd Q4FY25; 11% rise in Profits","author":"Divyansh_Kasana","date":"June 5, 2025","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q4FY25 of \u20b91,170.00 Crores up from \u20b91,054.00 Crore year on year, a rise of 11.01%. Total Expenses for Q4FY25 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":160884,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q4fy24-39-rise-in-profits\/","url_meta":{"origin":167018,"position":2},"title":"Ajanta Pharma Ltd Q4FY24; 39% rise in Profits","author":"Divyansh_Kasana","date":"May 7, 2024","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q4FY24 of \u20b9926.00 Crores up from \u20b9849.00 Crore year on year, a rise of 9.07%. Total Expenses for Q4FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":150232,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q1fy24-19-rise-in-profits\/","url_meta":{"origin":167018,"position":3},"title":"Ajanta Pharma Ltd Q1FY24; 19% rise in Profits.","author":"Divyansh_Kasana","date":"July 27, 2023","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported Revenues for Q1FY24 of \u20b91,021.00 Crores up from \u20b9951.00 Crore year on year, a rise of 7.36%. Total Expenses for Q1FY24 of \u20b9784.00 Crores up from \u20b9762.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":163587,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q1fy25-18-rise-in-profits\/","url_meta":{"origin":167018,"position":4},"title":"Ajanta Pharma Ltd Q1FY25; 18% rise in Profits","author":"Divyansh_Kasana","date":"August 5, 2024","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported Revenues for Q1FY25 of \u20b91,145.00 Crores up from \u20b91,021.00 Crore year on year, a rise of 12.14%. Total Expenses for Q1FY25 of \u20b9850.00 Crores up from \u20b9784.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-24.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-24.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-24.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-24.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-24.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-24.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":155773,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q2fy24-24-rise-in-profits\/","url_meta":{"origin":167018,"position":5},"title":"Ajanta Pharma Ltd Q2FY24; 24% rise in Profits","author":"Divyansh_Kasana","date":"November 6, 2023","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported Revenues for Q2FY24 of \u20b91,028.00 Crores up from \u20b9938.00 Crore year on year, a rise of 9.59%. Total Expenses for Q2FY24 of \u20b9774.00 Crores down from \u20b9776.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/167018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=167018"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/167018\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/167019"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=167018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=167018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=167018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}